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We have generated several hundred lines of zebrafish (Danio rerio), each heterozygous for a recessive embryonic lethal
mutation. Since many tumor suppressor genes are recessive lethals, we screened our colony for lines that display early
mortality and/or gross evidence of tumors. We identified 12 lines with elevated cancer incidence. Fish from these lines
develop malignant peripheral nerve sheath tumors, and in some cases also other tumor types, with moderate to very
high frequencies. Surprisingly, 11 of the 12 lines were each heterozygous for a mutation in a different ribosomal
protein (RP) gene, while one line was heterozygous for a mutation in a zebrafish paralog of the human and mouse
tumor suppressor gene, neurofibromatosis type 2. Our findings suggest that many RP genes may act as
haploinsufficient tumor suppressors in fish. Many RP genes might also be cancer genes in humans, where their role
in tumorigenesis could easily have escaped detection up to now.
Introduction
The zebraﬁsh (Danio rerio) has long been used as a model
organism for the identiﬁcation of genes required for early
vertebrate development (Kimmel 1989). There is reason to
believe that the zebraﬁsh can also be used in genetic screens
to identify cancer genes. Zebraﬁsh can live for 4–5 y (Gerhard
et al. 2002), and like other ﬁsh species (Schmale et al. 1986;
Wittbrodt et al. 1989), they develop tumors in a variety of
tissues (Amatruda and Zon 2002; Smolowitz et al. 2002). They
are also susceptible to chemical carcinogens and to well-
known oncogenes, in a manner similar to the conventional
mouse models (Beckwith et al. 2000; Spitsbergen et al. 2000a,
2000b; Langenau et al. 2003). Many of the spontaneous and
chemically- or oncogene-induced tumor types are histologi-
cally similar to their mammalian counterparts (Amatruda and
Zon 2002; Langenau et al. 2003).
The normal functions of many mammalian tumor sup-
pressor genes are required for normal development (Jacks
1996). In fact, nonessential tumor suppressors, such as p53
(Donehower et al. 1992), appear to be the exception rather
than the rule. These ﬁndings raised the possibility that one
could discover genes with a role in tumorigenesis among
zebraﬁsh genes identiﬁed initially for having essential roles
during embryonic development. We have used retroviral
vectors as a mutagen in a large-scale insertional mutagenesis
screen and have isolated many zebraﬁsh mutants with lesions
in genes essential for embryogenesis (Amsterdam et al. 1999;
Golling et al. 2002). We are maintaining approximately 500
lines, in most of which an embryonic lethal mutation is linked
to a single proviral insert. We have identiﬁed the mutated
genes in over 400 of the lines, and these include mutations in
300 distinct zebraﬁsh genes. To maintain the lines, we identify
approximately 15 heterozygous carriers and outcross these at
15–20 mo of age to produce the subsequent generation. The
maintenance of these mutations in adults provides a unique
opportunity to ask whether heterozygosity in genes required
for embryonic development predisposes the animals to
cancer. Here we describe how such an analysis has identiﬁed
genes that encode ribosomal proteins (RPs) as cancer genes in
zebraﬁsh.
Results
Mutations in Many RP Genes Predispose Zebrafish to
Malignant Peripheral Nerve Sheath Tumors and Other
Cancers
In the course of establishing and maintaining heterozygous
mutant lines of ﬁsh, we noticed several lines that displayed
early mortality by 2 y of age, and this phenotype was seen in
successive generations. Typically, only about 10% to 15% of
the ﬁsh in a tank are lost by 2 y of age, but in these apparently
high-mortality lines losses sometimes exceeded 50%. Fur-
thermore, ﬁsh from these lines were often found to have gross
lumps (Figure 1A and 1B). Histological analysis of step
sections showed that the growths were predominantly large,
malignant spindle cell tumors that were highly invasive, had a
high mitotic index, and often exhibited focal necrosis (Figure
1C–1H). The tumor cells were aligned into stacks and fascicles
to form a whirling, storiform pattern (Figure 1E–1H) that
resembled malignant peripheral nerve sheath tumors
(MPNSTs) seen in other species of ﬁsh (Schmale et al. 1983;
Roberts 2001) and in mammals (Cichowski et al. 1999;
Jimenez-Heffernan et al. 1999; Woodruff 1999). In keeping
with the published work on ﬁsh tumors, while adhering to the
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PLoS BIOLOGYcaution suggested by the National Neuroﬁbromatosis Foun-
dation regarding animal models of MPNST (M. McLaughlin,
personal communication), we have designated these tumors
zMPNSTs (zebraﬁsh MPNSTs).
Although we had occasionally observed individual ﬁsh with
lumps in our colony, it was unusual to ﬁnd so many within a
single line. Thus, we reasoned that the lines with early
mortality that also frequently displayed gross lumps by 2 y of
age might be lines with elevated rates of lethal cancer.
Surprisingly, we found that the several potentially high-
tumor lines were all heterozygous for mutations in genes that
encode different RPs. This unexpected observation, com-
bined with the knowledge that many tumor suppressors are
recessive embryonic lethal genes, prompted us to survey our
colony systematically to determine the incidence and
spectrum of tumors arising in the colony as a whole, and to
ask speciﬁcally whether genes that encode many different RPs
predispose to cancer.
To determine cancer incidence in the colony as a whole, we
sectioned 152 ‘‘control’’ ﬁsh that were 20–26 mo of age.
Forty-nine of the control ﬁsh were nontransgenic, while 103
were selected at random from 54 lines heterozygous for
mutations in genes other than RP genes. The latter ﬁsh had
been generated and maintained in a comparable manner to
our RP mutant lines and thus were appropriate controls. The
incidence of tumors detected by step sectioning in this
control population was 11% (Table 1D). Although we
observed a variety of different tumor types (most frequently
seminomas and pancreatic islet cell adenomas), most of the
tumors (15/17) were benign neoplasias and none were
zMPNSTs. There was neither a signiﬁcant difference in
spectrum nor an increase in incidence of tumors in the
non-RP heterozygous mutant ﬁsh relative to the wild-type
ﬁsh, indicating that the presence of viral insertions, per se,
does not have an obvious effect on tumorigenicity.
To compare the frequency and types of tumors arising in
RP mutant lines with those of the control population, we
established the fate of all heterozygotes in a single generation
of each of 16 RP mutant lines. In each family, some ﬁsh were
lost prior to any observation of external symptoms, preclud-
ing determination of the cause of death. The rest were
sacriﬁced either when they developed visible masses or when
they reached 18 or 22 mo of age, and step sections were
examined (Table 1). The 16 RP families fell into three groups
with respect to tumor incidence. Six lines had high mortality
(including both lost ﬁsh and those with external growths) and
Figure 1. Spindle Cell Tumors Resembling
MPNSTs in Zebrafish Heterozygous for
Mutations in RP Genes
(A and B) Fish with apparent masses, as
indicated by the arrows, or other evident
pathology were selected for histological
analysis: (A) a hi2582 ﬁsh, (B) a hi1034B
ﬁsh.
(C–H) Histopathology of representative
tumors stained with hematoxylin and
eosin reveals patterns consistent with the
diagnosis of MPNST in hi10 ﬁsh (C and
D), hi1974 ﬁsh (E–G), and hi1807 ﬁsh (H).
(C) Tumors typically ﬁlled the entire
abdomen (sb, swim bladder; br, brain)
(803).
(D) A large tumor with central necrosis is
seen emanating from the optic nerve (n)
(e, eye) (203).
(E) Tumors consist of spindle cells that
stack into short fascicles, typically or-
ganizing into whorls (4003).
(F) Tumor is aggressively invading
muscle (m) and gill (g) (br, brain) (1003).
(G) Mitotic ﬁgures (arrows) are evident
(10003).
(H) Areas of focal necrosis (arrows) are
frequently seen (2003).
DOI: 10.1371/journal.pbio.0020139.g001
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Tumor Suppressor Genes in Zebrafisha high tumor incidence (60% or more, including both ﬁsh
with gross tumors and tumors detected only upon sectioning).
Nearly all of the tumors observed by 22 mo in these lines were
zMPNSTs (Table 1A). These lines included those with
mutations in RP genes S8, S15a, L7, L35, L36, and L36a. Five
RP mutant lines made up a second group. These lines had
either a moderate incidence of cancer, or had a low incidence
but were unusual in having an apparently elevated incidence
of zMPNSTs. This group included lines with mutations in L13,
L23a, S7, S18, and S29. As in the high-cancer lines, in most
lines with moderate cancer incidence, most tumors observed
in ﬁsh by 22–24 mo of age were zMPNSTs (Table 1B). In one
line (hi1026, with a mutation in S18), however, other tumor
types predominated, suggesting that RP mutations can
increase the frequency of tumor types besides zMPNSTs.
The third group of RP mutant lines included ﬁve lines that
were not tumor prone. These lines, with mutations in L3, L24,
LP1, S12, and S15, were indistinguishable from controls in
tumor incidence and spectrum (Table 1C versus 1D). In
summary, 11 of 16 RP mutant lines had an elevated incidence
of cancer, and most of these 11 lines are predisposed to
develop zMPNSTs.
Together these ﬁndings suggest that zMPNSTs are rare in
our colony except in RP mutant lines. However, because the
cancer incidence was low in the control ﬁsh, we observed only
17 tumors in this group of ﬁsh in the experiment described
above. Furthermore, only four of these 17 tumors were
grossly visible, with 13 being detected only after sectioning.
To obtain more data on tumor spectrum in our colony,
including the types of tumors that present as externally
visible growths in non-RP mutant lines and wild type, we
sought out ﬁsh with externally visible tumors from through-
out our colony, coded them to avoid bias, and identiﬁed the
tumor types by histological analysis of step sections. In total,
we analyzed gross tumors from 41 control ﬁsh (wild type or
non-RP mutant lines, including the four tumors found
above). We also analyzed a total of 65 RP heterozygotes with
grossly visible tumors (including the ﬁsh represented in Table
1A–1C). Figure 2 shows a comparison of the types of tumors
in control versus RP mutant lines that presented as externally
visible growths. In the control ﬁsh, seminomas accounted for
57% of these tumors, while a wide variety of other tumor
types, including ultimobranchial gland tumors, neuroblasto-
mas, islet cell adenomas, and lymphomas, each arose at low
frequency. Overall, 69% of the grossly visible tumors
observed in non-RP ﬁsh were benign. Only 10% of these
externally visible tumors were zMPNSTs (see below). In
contrast to the control ﬁsh, and as is apparent from the data
in Table 1, the majority of grossly visible tumors in the RP
mutants were zMPNSTs (81%), greatly exceeding the number
of seminomas (4%) or other (15%) tumor types (Figure 2).
Since ﬁsh with external growths were found far more often
Table 1. Tumor Incidence in Zebrafish RP-Heterozygous Lines and in the Colony
Gene Line Age Range Initial
Number
of Fish
Number
Lost
Number of
Grossly-
Apparent
Tumors/
Number
of Fish
Examined
Number of
Tumor-
Bearing
Fish/
Number
of Fish
Examined
Number of
zMPNST/
Number of
Fish Examined
Tumor Incidence
A L35 hi258 up to 21.5 mo 13 7 5/6 6/6 6/6 100%
S15a hi2649 up to 18 mo 9 2 4/7 6*/7 5/7 86%
S8 hi1974 up to 22 mo 19 6 6/13 9/13 8/13 69%
L36a hi10 up to 22 mo 14 6 4/8 5/8 5/8 63%
L36 hi1807 up to 21.5 mo 14 6 4/8 5/8 4/8 63%
L7 hi1061 up to 22 mo 14 4 6/10 6
a/10 5/10 60%
B S7 hi1034B up to 22 mo 19 4 3/15 7/15 5/15 47%
L13 hi1016 up to 23 mo 15 4 2/11 5/11 3/11 45%
S18 hi1026 up to 24 mo 23 9 1/14 6/14 1/14 43%
S29 hi2903 up to 22 mo 18 3 4/15 4/15 4/15 27%
L23A hi2582 up to 22 mo 40 5 3/35 5/35 4/35 14%
C S12 hi1227 all at 22 mo 14 1 0/13 1/13 0/13 8%
acidic LP1 hi1444 up to 22.5 mo 18 0 1/18 1/18 0/18 6%
L3 hi2437 all at 23 mo 19 2 0/17 1/17 0/17 6%
L24 hi1284 all at 26 mo 18 0 0/18 0/18 0/18 0%
S15 hi2430 all at 23 mo 16 0 0/16 0/16 0/16 0%
D NA Colony 20–26 mo 152 ND 4/152 17/152 0/152 11%
aOne individual had two tumors, each of which was malignant.
RP animals were collected as tumors became apparent, or as healthy animals at the maximum age specified (age range). Number lost indicates those that either died before
the appearance of external symptoms or were lost from their tanks. Control animals from the colony were selected without regard to gross appearance. Incidence rates are
based on the number of fish examined histologically (that is, excluding lost fish).
DOI: 10.1371/journal.pbio.0020139.t001
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Tumor Suppressor Genes in Zebrafishwithin RP families than in the colony at large, the dramatic
shift in the spectrum of tumors in RP relative to non-RP
mutant lines reﬂects the profound increase in incidence of
zMPNSTs rather than any obvious reduction in the incidence
of seminomas and other tumor types.
As noted above, we detected zMPNSTs in only four of 41
control ﬁsh with grossly visible tumors. Two of these ﬁsh,
aged 15 and 24.5 mo, were from the hi3332 line, the only non-
RP line in which more than a single zMPNST has been
observed to date. Signiﬁcantly, the viral insertion that is
linked to the embryonic lethal phenotype of this line lies
within one (NF2a) of two distinct zebraﬁsh genes that are
highly homologous to the mammalian neuroﬁbromatosis type
2 gene (NF2). The insertion abrogates expression of this gene
in homozygous mutant embryos (Figure S1 and data not
shown). NF2 was originally identiﬁed as a tumor suppressor
gene that predisposes individuals to develop tumors of the
nervous system (Trofatter et al. 1993; Ruttledge et al. 1994).
Given this ﬁnding, we screened the remaining 53 ﬁsh in this
family for tumors between 17.5 and 23 mo of age by
sectioning. Seven of these 53 ﬁsh had small spindle cell
tumors. These tumors were not identical to typical zMPNSTs
found in RP families, but shared some key characteristics
(data not shown). Given the elevated incidence of rare tumor
types including zMPNSTs, we conclude that NF2a acts as a
tumor suppressor gene in ﬁsh, as it does in mammals.
Early Mortality in an RP Mutant Line Results from Multiple
Types of Cancer
The experiment described above identiﬁed six RP mutant
lines with high mortality. While some of the mortality could
be accounted for by ﬁsh that displayed gross tumors and
therefore were removed from the tanks before they died,
many ﬁsh simply disappeared or were found dead and were
too deteriorated to be analyzed histologically. To determine
whether early mortality in these lines was entirely due to
lethal cancers, and if so, whether it was due to zMPNSTs or to
other tumor types, we performed two experiments using ﬁsh
from the early-mortality, high-tumor hi10 line. In one
experiment we screened hi10 heterozygotes and their wild-
type siblings weekly for evidence of ill health or externally
visible growths in an effort to catch all sick ﬁsh before they
died or were lost. Sickly ﬁsh were sacriﬁced and subjected to
histological examination, as were all of the ﬁsh that still
appeared healthy at 22 mo of age. The results are shown in
Figure 3. Only the RP heterozygous carrier ﬁsh displayed
early mortality, and, as anticipated, this was due to cancers.
Strikingly, among tumors found by 15 mo of age, while two
were zMPNSTs, one was a retinoblastoma and three were
lymphomas, tumor types that, like zMPNSTs, arise infre-
quently in our control populations. The tumors detected in
the older ﬁsh were predominantly zMPNSTs. By the endpoint
of the experiment (22 mo) all of the noncarrier sibling
controls appeared healthy, and step sectioning detected only
one tumor-bearing ﬁsh among 13, a frequency comparable to
the control population. These results support the conclusion
that the early mortality observed in the hi10 line is the result
of lethal tumors, and reveal that these include zMPNSTs but
also other tumor types.
Further evidence that ﬁsh from the hi10 line are predis-
posed to multiple tumor types was obtained in the second
experiment, in which we sectioned hi10 heterozygotes and
their noncarrier sibling controls (speciﬁcally including any
sick or growth-bearing ﬁsh along with apparently healthy ﬁsh)
at approximately six-week intervals between eight and 14 mo
of age. As shown in Table 2, we found both grossly visible and
occult zMPNSTs and other tumor types in the hi10 carrier
ﬁsh. Thus, the hi10 line (and presumably other high-mortality
RP lines) is predisposed to multiple tumor types, though
particularly strongly predisposed to develop zMPNSTs,
especially at later time points.
RP Genes May Be Haploinsufficient Tumor Suppressors
Dominant mutations that predispose vertebrates to cancer
can be activated oncogenes, recessive tumor suppressors, or
haploinsufﬁcient tumor suppressors (Largaespada 2001).
Several lines of evidence suggest that RP mutant genes may
be acting as haploinsufﬁcient tumor suppressors in zebraﬁsh.
The mutagenic inserts in all of our RP mutant lines reduced
or eliminated expression of the RP gene, as determined by
RT-PCR and, in some cases, Northern blotting (Figure 4A and
data not shown). Thus, most if not all of these viral insertions
appear to be loss-of-function mutations. This suggests that
the RP genes are not mutated to form activated oncogenes,
Figure 2. The Tumor Spectrum in Fish Heterozygous for Mutations in RP
Genes Shows an Increased Proportion of zMPNSTs
Fish with apparent masses were selected and processed for
histological analysis. Numbers are shown as percent of the total
number of diagnosed tumors from either population. The control
group includes 42 tumors from 41 ﬁsh, including both wild-type and
non-RP family transgenics. The RP group includes 68 tumors from 65
RP heterozygotes from 18 different lines representing mutations in
16 different genes. The ‘‘other’’ tumor category includes pancreatic
islet adenomas, ultimobranchial gland tumors, neuroblastomas,
retinoblastomas, lymphomas, ganglioneuromas, ductal carcinomas,
gastrointestinal adenocarcinomas, hepatocellular carcinomas, leuke-
mias, meningiomas, and histiocytic sarcomas.
DOI: 10.1371/journal.pbio.0020139.g002
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Tumor Suppressor Genes in ZebrafishFigure 3. Rate of Tumor Appearance in
hi10 Heterozygotes
A cohort of 28 hi10 ﬁsh and 13 of their
noncarrier siblings were observed over
22 mo for the appearance of ill health or
externally visible tumors. Symptomatic
individuals were sacriﬁced, ﬁxed, and
sectioned for histological analysis. The
graph represents the percentage of ﬁsh
remaining over time, with the diagnosis
of each removed ﬁsh. Three ﬁsh labeled
‘‘dead’’ died before ﬁxation and had too
much tissue damage to establish a
diagnosis. Also, seven of the carrier ﬁsh
(though none of the noncarriers) were
lost to unknown causes over the course
of the experiment; while they most likely
d i e d ,t ob ec o n s e r v a t i v et h e s ew e r e
removed from the total number of ﬁsh
charted. At 22 mo, the remaining exter-
nally healthy ﬁsh (4/21 carriers, 13/13
noncarriers) were also histologically ex-
amined, and the status of these ﬁsh is
indicated.
DOI: 10.1371/journal.pbio.0020139.g003
Table 2. Onset of Tumor Development in hi10 Fish and Noncarrier Siblings
Age (in months) Carriers Non-carriers
Fish
with
External
Growth
or Sick
Fish
Collected
for
Histology
Total
Tumor-
Bearing
Fish
Tumor
Types
Fish
with
External
Growth
or Sick
Fish
Collected
for
Histology
Total
Tumor-
Bearing
Fish
Tumor
Types
7.4–8.3 2 19 4
a 1 lymphoma,
3 zMPNST (2 occult),
1 occult histiocytic
sarcoma
1 19 1 Tumor of
uncertain
origin
9.2 1 10 2 1 zMPNST,
1 occult gut
adenocarcinoma
01 00
10–10.6 4 9 5 4 zMPNST,
1 occult renal cell
carcinoma
08 0
11.9–12.5 5 12 8* 7 zMPNST (3 occult),
1 occult gut
adenocarcinoma,
1 uncertain origin
01 00
14 4 13 8 1 lymphoma,
5 zMPNST (2 occult),
1 occult pancreatic
ductal carcinoma,
1 occult uncertain origin
01 00
aOne fish at each of these time points had two tumors.
Carriers: starting population was 70 fish; seven fish were lost over the course of the experiment. Noncarriers: starting population was 92 fish; three fish were lost over the
course of the experiment; 32 externally healthy fish at the end of the study (14 mo) were not histologically examined.
DOI: 10.1371/journal.pbio.0020139.t002
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Tumor Suppressor Genes in Zebrafishbut rather may act as tumor suppressors. In mammals, the
most frequent mechanism of inactivation of recessive tumor
suppressor genes is the acquisition of a mutation (either
germline or somatic) in one allele and subsequent loss of the
wild-type allele through loss of heterozygosity (LOH) (Haber
and Harlow 1997). Thus, we investigated whether the wild-
type RP gene had been lost in the zebraﬁsh tumors. We
isolated both normal and tumor tissue from three RP
heterozygous mutant lines, hi10, hi258, and hi1974, each of
which showed a reduction in expression of its respective RP
mutant gene of 10-fold or more (Figure 4A) and examined
DNA from these samples for the presence of the mutant and
wild-type RP alleles by PCR (Figure 4B). In every case, we
detected the wild-type allele, arguing against LOH in these
tumors. A concern is that tissue contamination can yield
misleading LOH results, particularly because the red blood
cells of ﬁsh are nucleated. Thus control PCR experiments
were performed in which DNA samples from heterozygous
and homozygous embryos were mixed at different ratios. The
results show that our assay was sensitive to a decrease as small
as 3-fold in the relative amount of the wild-type allele (data
not shown). Thus, unless the tumor samples contained more
than 33% nontumor cells, we can conclude that the wild-type
RP alleles were not lost in these tumors and thus the RP genes
are probably not recessive tumor suppressors. In one of the
tumor samples shown in Figure 4, tumor hi10–1, the wild-type
allele appears not only to be present but possibly at higher
concentration than the mutant allele, and Southern analysis
of this same DNA sample supported this observation (data
not shown). Thus, in this particular tumor the mutant allele
may have been lost and only the wild-type allele retained.
In mice, a tumor cell line has been described in which one
copy of an RP gene is deleted and the other copy has suffered
a mutation that may contribute to tumorigenesis (Beck-
Engeser et al. 2001). To rule out the acquisition of a point
mutation in the wild-type allele in RP mutant tumors, all of
the coding exons of the appropriate RP gene and at least 50
bp of intronic sequence ﬂanking them were sequenced from
each normal and tumor DNA sample. There was no
indication of any point mutations in any of the tumors. The
apparent retention of the wild-type allele in the tumor cells
in these samples, and the fact that no point mutations were
observed in the wild-type RP genes in the tumor cell DNA,
suggests that it is not a second hit in these loci that leads to
tumorigenesis. Rather, the data obtained suggest that these
genes function as haploinsufﬁcient tumor suppressors in
zebraﬁsh.
RP Mutations Alter the Relative Amounts of 18S and 28S
rRNAs
In yeast, a decrease in the amount of at least some RP genes
results in a reduction in the amount of the corresponding
ribosomal subunit and a reduction in the number of
assembled ribosomes (Moritz et al. 1990). To determine if
this is also true in ﬁsh, we examined the relative amounts of
18S and 28S rRNA in homozygous mutant embryos compared
to sibling controls. Embryos from heterozygote crosses of
lines hi10, hi1974, and hi2649 were sorted by phenotype at 3
d post-fertilization, and total RNA was prepared from pools
of mutant or phenotypically wild-type sibling embryos.
Electrophoresis and ethidium bromide staining were used
to determine the amounts of 18S and 28S RNA, which we
Figure 4. RP Genes Appear to Be Hap-
loinsufficient Tumor Suppressors
(A) RP mutations decrease the amount of
RP gene expression. RNA was prepared
from 3-d-old homozygous mutant em-
bryos and their wild-type siblings, and
serial dilutions of ﬁrst strand cDNA were
used as templates for PCR. The decrease
in expression in the mutants can be
determined by the difference in the
dilution between wild type and mutant
where the PCR product amount dimin-
ishes. The actin control shows that the
total amount of mRNA was the same
between samples.
(B) LOH is not observed in RP mutant
tumors. DNA was prepared from tumors
(T) and normal tissue (N) from the same
ﬁsh, and PCR was conducted with three
primers that show the presence or
absence of both the insert-bearing (mu-
tant) and wild-type chromosomes. In
each case, the upper band is the wild-
type chromosome and the lower band is
the insert-bearing one. hi10 ﬁsh #1
normal (lane 1), tumor (lane 2); hi10 ﬁsh
#2 normal (lane 3), tumor (lane 4); hi258
ﬁsh normal (lane 5), tumor (lane 6);
hi1974 ﬁsh normal (lane 7), tumor (lane
8).
DOI: 10.1371/journal.pbio.0020139.g004
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Tumor Suppressor Genes in Zebrafishassume reﬂect the amounts of 40S and 60S ribosomal
subunits, respectively (Figure 5). As a loading control, the
same RNA samples were subjected to Northern analysis and
probed for beta actin (Figure 5). In each case we observed a
decrease in the overall amount of rRNA, and, signiﬁcantly, a
preferential loss of the rRNA found in the ribosomal subunit
with which the mutated RP was associated. Thus in hi10, in
which a component of the large ribosomal subunit was
mutated, while both 18S and 28S RNA levels were decreased,
the level of 28S RNA was affected more than that of 18S.
Conversely, in hi1974 and hi2649, in which components of
the small ribosomal subunit were mutated, the 28S RNA levels
were mildly reduced, but 18S RNA was sharply decreased. In
none of these cases was the actin level reduced, so the effect
was not simply a result of a reduction of cell number, RNA
degradation, or cell death. Thus, as in yeast, RP mutations in
ﬁsh that result in reduced gene expression lead to a relative
decrease in the amount of the subunit to which they belong as
measured by a decrease in rRNA.
Discussion
In this study, we have found that heterozygous mutations in
11 different ribosomal protein genes predispose zebraﬁsh to
cancer, predominantly to zMPNSTs, but also to other rare
tumor types. All of these mutations reduce RP gene
expression, indicating that these 11 genes are not oncogenes.
Moreover, in the tumors we examined, the wild-type allele
appeared to be present and did not contain point mutations;
thus these genes are not recessive tumor suppressors. Rather,
our ﬁndings suggest that these 11 genes are haploinsufﬁcient
tumor suppressor genes; that is, reducing their activities by
about a factor of two increases the likelihood of cancer. These
ﬁndings raise two important, unanswered questions: ﬁrst,
how do these mutations lead to cancer, and second, do similar
mutations cause cancer in humans?
How Do These Mutations Cause Cancer?
The ﬁnding that mutations in so many different RP genes,
including S7, S8, S15a, S18, S29, L7, L13, L23a, L35, L36, and
L36a, predispose to cancer suggests that a function shared by
RPs underlies their role in this phenotype. However, not all
RP genes were cancer genes: S12, S15, L3, L24, and LP1
heterozygotes appeared normal. This raises the possibility
that the oncogenic RP genes could conceivably share some
novel biological function independent of their role in the
ribosome and that inhibition of this function leads to tumor
formation. Individual RPs have been implicated in a wide
variety of biological functions, including cell cycle progres-
sion, apoptosis, and DNA damage responses (Ben-Ishai et al.
1990; Sonenberg 1993; Chen et al. 1998; Chen and Ioannou
1999; Hershey and Miyamoto 2000; Volarevic et al. 2000;
Volarevic and Thomas 2001; Lohrum et al. 2003), and it has
been suggested that their role in these processes may arise
independently of their role in the ribosome itself (Wool 1996;
Wool et al. 1996; Soulet et al. 2001). However, it seems
somewhat unlikely to us that there could be such an
important, yet still undetected function involving so many
different RPs. Thus, we favor the possibility that it is a shared,
ribosome-associated function that allows them to be tumor
suppressors. If so, then why were not all RP genes cancer
genes in this study? At present we can only speculate. We have
not found any correlation that distinguishes the RP genes
that predispose to cancer from those that do not. Both can
belong to either the large or the small ribosomal subunit, and
all the mutants show reduced gene expression. Possibly some
RP genes are normally expressed at higher levels than others,
so that a 50% reduction in their expression does not reduce
their protein level below some critical, hypothetical threshold
required for tumor suppression.
The best-known function shared by RPs is their role in the
assembly of ribosomal subunits, and as a result, their role in
translation. In homozygous mutant ﬁsh embryos, the RP
mutations reduce the amount of the rRNA of the subunit to
which they belong, and hence almost certainly reduce the
amount of the corresponding ribosomal subunit relative to
the remaining subunit. In yeast this is known to reduce the
number of ribosomes, and thus also to reduce the amount of
protein synthesis. How might this predispose to cancer? In
truth, we do not know, and suspect that understanding the
mechanism that explains these ﬁndings will lead to new
insights into growth control. At present we can only list our
speculations and several relevant observations.
Reduced protein synthesis could lead to a reduction in the
level of a critical tumor suppressor protein, or of a positive
regulator of apoptosis or differentiation, either of which
could favor growth. A reduction in ribosome number might
signal the cell to try to overcome the deﬁcit by making more
of the components required for ribosome biogenesis, and this
in turn might promote cell growth. Alternatively, a reduction
in the number of ribosomes might alter the identity of the
messages recruited to ribosomes—similar to the way that
modulation of the translational capacity of mammalian cells
by oncogenes such as Ras or Akt is known to alter the identity
of mRNAs recruited to polysomes—changing the translation
Figure 5. Ribosomal RNA Levels Are Reduced in RP Mutants
RNA was prepared from 3-d-old homozygous mutant embryos or
their wild-type siblings from lines hi10 (L36a), hi1974 (S8), and hi2649
(S15a), and RNA content was visualized by electrophoresis and
ethidium bromide staining. The ratio of 28S/18S as determined by
densitometry is shown below each lane. Note that L36a mutants show
a preferential loss of the 28S band by 1.5-fold, while S8 and S15a
mutants show a preferential loss of the 18S band by 1.9- and 1.8-fold,
respectively. These RNAs were also northern blotted and probed for
beta actin as an mRNA content control.
DOI: 10.1371/journal.pbio.0020139.g005
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Finally, and most speculative of these possibilities, reduced
ability of a ribosomal subunit to assemble properly might
generate a signal that cells interpret as growth-promoting.
For example, degradation of excess rRNA, a molecule with
many hairpins, might generate such a signal in the form of
RNAi.
Are RP Genes Cancer Genes in Other Vertebrates?
Given that so many different RP genes can be cancer genes
in ﬁsh, it seems surprising that they are not already a well-
known class of cancer genes in vertebrates. Only two
examples are known that suggest a role for RP mutations in
mammalian tumor susceptibility, one in mice and one in
humans. In the mouse study, two independent murine tumor
cell lines were found to express tumor antigens that were
mutated RPs (Beck-Engeser et al. 2001). In both cases, the
tumors were found to become more aggressive upon either
loss or mutation of the wild-type allele of the RP gene. It was
postulated that the mutant RPs might have an oncogenic
activity that was suppressed by the wild-type protein. Such a
mechanism does not seem to be involved in the tumors that
develop in the RP mutant ﬁsh described here, since we failed
to detect evidence of oncogenic activation of RP genes.
In humans, there is a possible association of mutations in
one particular RP gene with cancer: approximately 25% of
both sporadic and familial cases of Diamond-Blackfan anemia
(DBA) are associated with a mutation of rpS19 (Draptchin-
skaia et al. 1999), and this syndrome includes an increased
riskofdevelopingleukemia(Wasseretal.1978).Ithasbeen
demonstrated that the anemia is likely due to a block in
erythroid differentiation (Hamaguchi et al. 2002), but it is
currently unclear whether the leukemia is an indirect result
of the anemia, caused by a stimulation in the production of
hematopoietic precursors, or whether the rpS19 gene dosage
plays a direct role in tumorigenesis. It is important to note
that DBA is a multigenic disease with very heterogeneous
clinical presentation. While DBA patients in general have an
increased predisposition to certain cancers, it is not yet clear
whether this is true of the subset whose DBA is caused by
rpS19 mutation.
While these examples from mouse and human are
consistent with the idea that mutations in individual RP
genes might contribute to tumorigenesis in mammals, they
have seemed to be unusual examples, rather than suggesting
that RP genes in general might be potential cancer genes. Our
study suggests for the ﬁrst time, we believe, that this is a
general property of many RP genes. The possibility that a
reduction in ribosome levels might be oncogenic in mammals
is further supported by the fact that mutations in DKC1, a
pseudouridine synthase that is required for rRNA processing
and for properly functioning ribosomes, cause dyskeratosis
congenita, a disease characterized by both premature aging
and increased tumor susceptibility (Ruggero et al 2003).
If RP genes frequently cause human cancers, it is not at all
certain that their role would have been detected. Even a
deliberate search for their involvement in human cancers
would be difﬁcult because there are so many (80) RP genes.
This plethora of genes, the fact that it is hard to know which
tumor type(s) to examine for RP mutations, and the fact that
the mutations might lie in regulatory elements rather than
protein-coding regions of the genes would make such a
search difﬁcult. Nonetheless, given the high degree of
conservation of biological mechanisms among vertebrates, it
seems likely that rp mutations will prove to increase the
incidence of tumors in humans as they do in zebraﬁsh. If so, it
may be advantageous to devise diagnostic strategies based on
ribosomal protein levels or on a function that these proteins
share, for example, in translation, rather than on the analysis
of such a large number of individual genes.
In summary, by examining aging populations of mutant
lines of ﬁsh with defects in embryonic essential genes, we
identiﬁed a novel group of cancer genes. The ability to
identify cancer genes by screening populations of ﬁsh
heterozyogous for recessive embryonic mutations and the
reassuring ﬁnding that NF2a is a tumor suppressor gene in
this system demonstrate the power of large-scale, forward-
genetic screens in the zebraﬁsh to identify new disease
susceptibility genes.
Materials and Methods
Mutagenesis and maintenance of mutant lines. The insertional
mutagenesis screen was carried out as previously described (Am-
sterdam et al. 1999). Stocks of all lines were maintained by
outcrossing heterozygotes to nontransgenic ﬁsh, preparing DNA
from tail ﬁn biopsies of 8- to 18-wk-old ﬁsh, and performing PCR
with insert-speciﬁc primers for each line to identify heterozygotes.
Fixation and histology. Adult ﬁsh were euthanized in ice water and
ﬁxed within 30 min in Bouin’s solution, embedded in parafﬁn, and
sectioned as previously described (Moore et al. 2002).
LOH analysis. DNA was prepared from tumor tissue or tail tissue
isolated from ﬁsh prior to ﬁxation for histology. PCR was conducted
with one primer complementary to proviral sequence and two
primers complementary to sequences on either side of the insertion
for the appropriate mutation. Primer sequences were as follows: hi10:
10gen5 (59-CAGCACAGATTCTTGAAAGCGCC-39), 10gen3 (59- GCA-
TATGTAGCATCTCGAAGGTCC-39), and NU3X (59- TGATCTC-
GAGCCAAACCTACAGGTGGGGTC-39); hi258: 258A5a (59-
GGTACGTCTGTGCTTATGTTTGTGTC-39), 258A3a (59-TCTCAA-
GACTTCATCCATTCATAATTCTGC-39), and NU3X; hi1974: 1974c1
(59-CTACACCACAGGTATCTCAAGGG-39), 1974c1est3 (59-CCAC-
CACGGACTCTTATTGTGTG-39), and IPL3 (59-TGATCTC-
GAGTTCCTTGGGAGGGTCTCCTC-39).
RNA analysis. RNA was prepared from mutant and wild-type
embryos using Trizol reagent (Invitrogen, Carlsbad, California,
United States). For RT-PCR, serial dilutions of ﬁrst strand cDNA
were ampliﬁed for 30 (hi1974) or 35 (hi10 and hi258) cycles using the
following primers for the genes indicated: rpL36a: 10rt5 (59-
CAACCATGGTAAACGTACCGAAG-39) and 10RTR (59-CACAAAA-
GAAGCACTTGGCCCAGC-39); rpL35: 258RTF2 (59-
GCTGCTTCCAAGCTCTCAAAAATCC-39) and 258RTR (59-
TGCCTTGACGGCGAACTTGCGAATG-39); rpS8: 1974RTF1 (59-
TCTCAAGGGATAACTGGCACA-39) and 1974RTR1 (59-GAACTC-
CAGTTCTTTGCCCTC-39); actin: actinF (59-CATCAG-
CATGGCTTCTGCTCTGTATGG-39) and actinR (59-
GACTTGTCAGTGTACAGAGACACCCT-39). For visualization of
18S and 28S RNA, two embryo equivalents of RNA were electro-
phoresed through a nondenaturing agarose gel containing 0.5 lg/ml
ethidium bromide. For detection of beta actin RNA, four embryo
equivalents of RNA were electrophoresed through a 7.5% form-
aldehyde/MOPS-buffered agarose gel, blotted to Hybond Nþ (Amer-
sham Biosciences, Little Chalfont, United Kingdom), and hybridized
with a random primed beta actin probe.
Supporting Information
Figure S1. Position of Mutagenic Insertions
The genomic sequence of part of each of these genes is represented as
exonic (boxed) and promoter or intronic (line). White boxes
represent 59 UTR while shaded boxes represent coding exons. Where
no white boxes are shown, the location of the 59 UTR and beginning
of the coding region has not been determined relative to the part of
the locus shown here. In all cases, at least one coding exon (and all of
the 39 UTR) is downstream of the region of the gene represented
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each genomic sequence. All drawings are to the scale of the top scale
bar, except the rpl36 locus, which has its own scale bar.
Found at DOI: 10.1371/journal.pbio.0020139.sg001 (62 KB PDF).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank/) accession num-
bers for the genes discussed in this paper are L13 (AY561516), L23a
(AY561517), L24 (AY099532), L3 (AY561514), L35 (AF506205), L36
(AY561518), L36a (AY099511), L7 (AY561515), LP1 (AY561519), NF2a
(AY561520), S12 (AY561510), S15 (AY561511), S15a (AY561512), S18
(AY099517), S29 (AY561513), S7 (AY561508), and S8 (AY561509).
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